DE NOVO DONOR SPECIFIC ANTIBODIES (DNDSA) AND KIDNEY TRANSPLANTATION (KTX) OUTCOME: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Telli, Sara [1 ]
Sergi, Filomena [1 ]
Iaria, Giuseppe [1 ]
Poggi, Elvira [2 ]
Corrado, Federica [1 ]
Marzio, Silvio [1 ]
Petagna, Lorenzo [1 ]
Romano, Francesca [1 ]
Pisani, Gennaro [1 ]
Casella, Annachiara [1 ]
Parente, Alessandro [1 ]
Tisone, Giuseppe [1 ]
机构：
[1] Tor Vergata Univ, Transplant Surg, Rome, Italy
[2] CNR, Inst Translat Pharmacol, Rome, Italy
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
MP063
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [1] DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION - OUR EXPERIENCE OF CLINICAL RELEVANCE
    Dukic, Tatjana M.
    Simonovic, Ruzica B.
    Andric, Zorana P.
    Dmitrovic, Jelena M.
    HLA, 2019, 93 (05) : 311 - 311
  • [2] De Novo Donor Specific Antibodies (dnDSA) Is Associated with Cardiac Allograft Hypertrophy After Heart Transplantation (HT)
    Pereira, N. L.
    Valero, M. Jesus
    Wong, M.
    Kushwaha, S.
    Smith, B.
    Kremers, W.
    Gandhi, M.
    Richard, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04) : S228 - S228
  • [3] Clinical Outcome of Kidney Transplant Recipients with C1q-Binding De Novo Donor Specific Antibodies: A Single-Center Experience
    Marinaki, Smaragdi
    Vittoraki, Angeliki
    Tsiakas, Stathis
    Kofotolios, Ioannis
    Darema, Maria
    Ioannou, Sofia
    Vallianou, Kalliopi
    Boletis, John
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [4] Significance of De Novo Donor Specific DQ Antibodies after Kidney Transplantation
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Achkar, K. A.
    Knight, R. J.
    Dawson, K. L.
    Dilioglou, S.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
  • [5] THE IMPACT OF PRE-TRANSPLANT DONOR SPECIFIC ANTI-HLA ANTIBODIES ON OUTCOME OF KIDNEY TRANSPLANTATION - SINGLE CENTER EXPERIENCE
    Balaha, Mohamed Abdelmonem
    Alotaibi, Torki
    Roshdy, Amin
    Elansary, Mervat
    Ibrahim, Mona Aziz
    Zayed, Bahaa-Eldeen
    Gheith, Osama
    Tawab, Khaled Abdel
    Makkeyah, Yahya
    Nagib, Ayman Maher
    Zakaria, Zakaria Elsaid
    Halim, Medhat A.
    Mahmoud, Tarek S.
    Nair, Prasad
    TRANSPLANT INTERNATIONAL, 2017, 30 : 384 - 384
  • [6] Subclinical Antibody Mediated Rejection in Kidney Transplantation: Protocol Biopsy for De Novo Donor Specific Antibody, a Single-Center Experience
    Bertrand, D.
    Etienne, I.
    Hau, F.
    Guerrot, D.
    Hanoy, M.
    Le Roy, F.
    Legallicier, B.
    Francois, A.
    Godin, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 436 - 436
  • [7] Incidence and Clinical Significance of De Novo Donor Specific Antibodies after Kidney Transplantation
    Lionaki, Sophia
    Panagiotellis, Konstantinos
    Iniotaki, Aliki
    Boletis, John N.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [8] Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.
    Ho, B.
    Bhagat, H.
    Lee, E.
    Atiemo, K.
    Daud, A.
    Kang, R.
    Montag, S.
    Zhao, L.
    Schwartz, J.
    Ladner, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 224 - 225
  • [9] Urologic De Novo Malignancies After Kidney Transplantation: A Single Center Experience
    Karczewski, M.
    Czapiewski, W.
    Karczewski, J.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (05) : 1293 - 1297
  • [10] THE IMPACT OF DE NOVO DONOR SPECIFIC ANTIBODIES AND HLA HISTOCOMPATIBILITY IN LONGTERM KIDNEY TRANSPLANTATION OUTCOME (UP TO 27 YEARS)
    Fylaktou, Asimina
    Kasimatis, Efstratios
    Karampatakis, Theodoros
    Schoina, Maria
    Anastasiou, Aikaterini
    Boukla, Anna
    Nikolaidou, Vasiliki
    Papachristou, Marianthi
    Chronis, Theodoros
    Papagianni, Aikaterini
    HLA, 2018, 91 (05) : 357 - 358
12345